123 related articles for article (PubMed ID: 16217769)
1. Bulky DNA adducts as risk indicator of lung cancer in a Danish case-cohort study.
Bak H; Autrup H; Thomsen BL; Tjønneland A; Overvad K; Vogel U; Raaschou-Nielsen O; Loft S
Int J Cancer; 2006 Apr; 118(7):1618-22. PubMed ID: 16217769
[TBL] [Abstract][Full Text] [Related]
2. Lifestyle, environmental, and genetic predictors of bulky DNA adducts in a study population nested within a prospective Danish cohort.
Eriksen KT; Sørensen M; Autrup H; Vogel U; Overvad K; Tjønneland A; Loft S; Raaschou-Nielsen O
J Toxicol Environ Health A; 2010; 73(9):583-95. PubMed ID: 20391138
[TBL] [Abstract][Full Text] [Related]
3. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
[TBL] [Abstract][Full Text] [Related]
4. Aromatic adducts and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Spanish cohort.
Gilberson T; Peluso ME; Munia A; Luján-Barroso L; Sánchez MJ; Navarro C; Amiano P; Barricarte A; Quirós JR; Molina-Montes E; Sánchez-Cantalejo E; Tormo MJ; Chirlaque MD; Ardanaz E; Dorronsoro M; Confortini M; Bonet C; Sala N; González CA; Agudo A
Carcinogenesis; 2014 Sep; 35(9):2047-54. PubMed ID: 24845263
[TBL] [Abstract][Full Text] [Related]
5. DNA adducts and cancer risk in prospective studies: a pooled analysis and a meta-analysis.
Veglia F; Loft S; Matullo G; Peluso M; Munnia A; Perera F; Phillips DH; Tang D; Autrup H; Raaschou-Nielsen O; Tjønneland A; Vineis P;
Carcinogenesis; 2008 May; 29(5):932-6. PubMed ID: 18343884
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts.
Mollerup S; Berge G; Baera R; Skaug V; Hewer A; Phillips DH; Stangeland L; Haugen A
Int J Cancer; 2006 Aug; 119(4):741-4. PubMed ID: 16557573
[TBL] [Abstract][Full Text] [Related]
7. Bulky DNA adducts as risk indicators of lung cancer in a Danish case-cohort study.
Raaschou-Nielsen O; Thomsen BL; Overvad K; Tjønneland A; Vogel U; Bak H; Autrup H; Loft S
Int J Cancer; 2007 Jan; 120(1):212-3. PubMed ID: 17036326
[No Abstract] [Full Text] [Related]
8. Relationship between TP53 tumour suppressor gene mutations and smoking-related bulky DNA adducts in a lung cancer study population from Hungary.
Anna L; Holmila R; Kovács K; Gyorffy E; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Husgafvel-Pursiainen K; Schoket B
Mutagenesis; 2009 Nov; 24(6):475-80. PubMed ID: 19643813
[TBL] [Abstract][Full Text] [Related]
9. Re: "Bulky DNA adducts as risk indicators of lung cancer in a Danish case-cohort study".
Rundle A
Int J Cancer; 2007 Jan; 120(1):214. PubMed ID: 17036328
[No Abstract] [Full Text] [Related]
10. Bulky DNA adduct formation and risk of bladder cancer.
Castaño-Vinyals G; Talaska G; Rothman N; Alguacil J; Garcia-Closas M; Dosemeci M; Cantor KP; Malats N; Real FX; Silverman D; Serra C; Carrato A; Tardon A; Garcia-Closas R; Kogevinas M; Vermeulen R
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2155-9. PubMed ID: 17932365
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
[TBL] [Abstract][Full Text] [Related]
12. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls.
Hou SM; Fält S; Yang K; Nyberg F; Pershagen G; Hemminki K; Lambert B
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):133-40. PubMed ID: 11219770
[TBL] [Abstract][Full Text] [Related]
13. DNA adducts and lung cancer risk: a prospective study.
Peluso M; Munnia A; Hoek G; Krzyzanowski M; Veglia F; Airoldi L; Autrup H; Dunning A; Garte S; Hainaut P; Malaveille C; Gormally E; Matullo G; Overvad K; Raaschou-Nielsen O; Clavel-Chapelon F; Linseisen J; Boeing H; Trichopoulou A; Trichopoulos D; Kaladidi A; Palli D; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita HB; Peeters PH; Kumle M; Gonzalez CA; Martinez C; Dorronsoro M; Barricarte A; Navarro C; Quiros JR; Berglund G; Janzon L; Jarvholm B; Day NE; Key TJ; Saracci R; Kaaks R; Riboli E; Vineis P
Cancer Res; 2005 Sep; 65(17):8042-8. PubMed ID: 16140979
[TBL] [Abstract][Full Text] [Related]
14. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
[TBL] [Abstract][Full Text] [Related]
15. Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study.
Tang D; Phillips DH; Stampfer M; Mooney LA; Hsu Y; Cho S; Tsai WY; Ma J; Cole KJ; Shé MN; Perera FP
Cancer Res; 2001 Sep; 61(18):6708-12. PubMed ID: 11559540
[TBL] [Abstract][Full Text] [Related]
16. Bulky DNA Adducts, Tobacco Smoking, Genetic Susceptibility, and Lung Cancer Risk.
Munnia A; Giese RW; Polvani S; Galli A; Cellai F; Peluso MEM
Adv Clin Chem; 2017; 81():231-277. PubMed ID: 28629590
[TBL] [Abstract][Full Text] [Related]
17. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer.
Li D; Wang M; Cheng L; Spitz MR; Hittelman WN; Wei Q
Cancer Res; 1996 Aug; 56(16):3638-41. PubMed ID: 8705998
[TBL] [Abstract][Full Text] [Related]
18. Early age at smoking initiation and tobacco carcinogen DNA damage in the lung.
Wiencke JK; Thurston SW; Kelsey KT; Varkonyi A; Wain JC; Mark EJ; Christiani DC
J Natl Cancer Inst; 1999 Apr; 91(7):614-9. PubMed ID: 10203280
[TBL] [Abstract][Full Text] [Related]
19. Bulky DNA adducts and risk of cancer: a meta-analysis.
Veglia F; Matullo G; Vineis P
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):157-60. PubMed ID: 12582026
[TBL] [Abstract][Full Text] [Related]
20. Smoking-related O4-ethylthymidine formation in human lung tissue and comparisons with bulky DNA adducts.
Anna L; Kovács K; Gyorffy E; Schoket B; Nair J
Mutagenesis; 2011 Jul; 26(4):523-7. PubMed ID: 21454326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
